BEAM
Price
$24.91
Change
-$0.48 (-1.89%)
Updated
Oct 14, 01:14 PM (EDT)
Capitalization
2.57B
27 days until earnings call
Intraday Buy/Sell Signals
MGNX
Price
$1.59
Change
-$0.04 (-2.44%)
Updated
Oct 14, 01:31 PM (EDT)
Capitalization
103.66M
28 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

BEAM vs MGNX

Header iconBEAM vs MGNX Comparison
Open Charts BEAM vs MGNXBanner chart's image
Beam Therapeutics
Price$24.91
Change-$0.48 (-1.89%)
Volume$600
Capitalization2.57B
MacroGenics
Price$1.59
Change-$0.04 (-2.44%)
Volume$5.6K
Capitalization103.66M
BEAM vs MGNX Comparison Chart in %
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. MGNX commentary
Oct 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and MGNX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 14, 2025
Stock price -- (BEAM: $25.39 vs. MGNX: $1.64)
Brand notoriety: BEAM and MGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 104% vs. MGNX: 64%
Market capitalization -- BEAM: $2.57B vs. MGNX: $103.66M
BEAM [@Biotechnology] is valued at $2.57B. MGNX’s [@Biotechnology] market capitalization is $103.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $104.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileMGNX’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • MGNX’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than MGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while MGNX’s TA Score has 6 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 4 bearish.
  • MGNX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, MGNX is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -1.93% price change this week, while MGNX (@Biotechnology) price change was -6.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.52%. For the same industry, the average monthly price growth was +13.94%, and the average quarterly price growth was +279.73%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

MGNX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+0.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.57B) has a higher market cap than MGNX($104M). BEAM YTD gains are higher at: 2.379 vs. MGNX (-49.538). MGNX has higher annual earnings (EBITDA): -26.91M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. MGNX (176M). MGNX has less debt than BEAM: MGNX (37.2M) vs BEAM (155M). MGNX has higher revenues than BEAM: MGNX (164M) vs BEAM (60.3M).
BEAMMGNXBEAM / MGNX
Capitalization2.57B104M2,470%
EBITDA-414.33M-26.91M1,539%
Gain YTD2.379-49.538-5%
P/E RatioN/AN/A-
Revenue60.3M164M37%
Total Cash1.15B176M653%
Total Debt155M37.2M417%
FUNDAMENTALS RATINGS
MGNX: Fundamental Ratings
MGNX
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMMGNX
RSI
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 7 days ago
90%
Momentum
ODDS (%)
Bullish Trend 12 days ago
77%
Bullish Trend 7 days ago
78%
MACD
ODDS (%)
N/A
Bullish Trend 7 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 7 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 7 days ago
85%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Bullish Trend 12 days ago
83%
Declines
ODDS (%)
Bearish Trend 19 days ago
85%
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 7 days ago
75%
Bullish Trend 7 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KNRRY23.430.29
+1.25%
Knorr-Bremse
SECCF3.18N/A
N/A
Serco Group Plc.
STBMF0.35N/A
N/A
St. Barbara Ltd.
RTEZ70.00N/A
N/A
Rest EZ, Inc.
ENDGF0.19-0.01
-3.10%
Endurance Gold Corp.

MGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGNX has been loosely correlated with RGNX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if MGNX jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGNX
1D Price
Change %
MGNX100%
-2.96%
RGNX - MGNX
52%
Loosely correlated
+3.85%
CRBU - MGNX
52%
Loosely correlated
-4.42%
XNCR - MGNX
52%
Loosely correlated
+7.14%
BEAM - MGNX
50%
Loosely correlated
-3.53%
SYRE - MGNX
48%
Loosely correlated
-1.18%
More